[1] Chen W, Zheng R, Zhang S, et al. Report of incidence and mortality in China cancer registries, 2009. Chin J Cancer Res. 2013;25(1):10-21.[2] Kim TH, Shivdasani RA. Stomach development, stem cells and disease. Development. 2016;143(4):554-565.[3] Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4): 271-289.[4] Zhang X, Hua R, Wang X, et al. Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer. Oncotarget. 2016;7(9):9815-9831. [5] Zhang WJ, Zhou ZH, Guo M, et al. High Infiltration of Polarized CD163+ Tumor-Associated Macrophages Correlates with Aberrant Expressions of CSCs Markers, and Predicts Prognosis in Patients with Recurrent Gastric Cancer. J Cancer. 2017;8(3):363-370.[6] Liu S, Clouthier SG, Wicha MS. Role of microRNAs in the regulation of breast cancer stem cells. J Mammary Gland Biol Neoplasia. 2012;17(1):15-21.[7] Liu N, Zhong L, Zeng J, et al. Upregulation of microRNA-200a associates with tumor proliferation, CSCs phenotype and chemosensitivity in ovarian cancer. Neoplasma. 2015;62(4): 550-559.[8] Lee SJ, Seo JW, Chae YS, et al. Genetic polymorphism of miR-196a as a prognostic biomarker for early breast cancer. Anticancer Res. 2014;34(6):2943-2949.[9] Gocze K, Gombos K, Juhasz K, et al. Unique microRNA expression profiles in cervical cancer. Anticancer Res. 2013; 33(6):2561-2567.[10] Sun M, Liu XH, Li JH, et al. MiR-196a is upregulated in gastric cancer and promotes cell proliferation by downregulating p27(kip1). Mol Cancer Ther. 2012;11(4):842-852.[11] Tsai MM, Wang CS, Tsai CY, et al. MicroRNA-196a/-196b promote cell metastasis via negative regulation of radixin in human gastric cancer. Cancer Lett. 2014;351(2):222-231. [12] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7-30.[13] Zhang J, Gan L, Xu MD, et al. The prognostic value of age in non-metastatic gastric cancer after gastrectomy: a retrospective study in the U.S. and China. J Cancer. 2018; 9(7):1188-1199.[14] Yin J, Song JN, Bai ZG, et al. Gastric Cancer Mortality Trends in China (2006-2013) Reveal Increasing Mortality in Young Subjects. Anticancer Res. 2017;37(8):4671-4679.[15] 邹文斌,杨帆,李兆申.中国胃癌诊治关键在于提高早期诊断率[J].浙江大学学报:医学版,2015,44(1):9-14,53. [16] Mitra A, Mishra L, Li S. EMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget. 2015;6(13): 10697-10711.[17] Jeong YJ, Oh HK, Park SH, et al. Association between inflammation and cancer stem cell phenotype in breast cancer. Oncol Lett. 2018;15(2):2380-2386.[18] Carmon KS, Gong X, Yi J, et al. LGR5 receptor promotes cell-cell adhesion in stem cells and colon cancer cells via the IQGAP1-Rac1 pathway. J Biol Chem. 2017;292(36): 14989-15001. [19] Wang M, Yang F, Qiu R, et al. The role of mmu-miR-155-5p-NF-κB signaling in the education of bone marrow-derived mesenchymal stem cells by gastric cancer cells. Cancer Med. 2018;7(3):856-868.[20] Takaishi S, Okumura T, Tu S, et al. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells. 2009;27(5):1006-1020.[21] Han S, Guo J, Liu Y, et al. Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation. Oncotarget. 2015;6(42): 44452-44465.[22] Senel F, Kökenek Unal TD, Karaman H, et al. Prognostic Value of Cancer Stem Cell Markers CD44 and ALDH1/2 in Gastric Cancer Cases. Asian Pac J Cancer Prev. 2017;18(9): 2527-2531. [23] Zhang C, Li C, He F, et al. Identification of CD44+CD24+ gastric cancer stem cells. J Cancer Res Clin Oncol. 2011; 137(11):1679-1686.[24] Song Z, Yue W, Wei B, et al. Sonic hedgehog pathway is essential for maintenance of cancer stem-like cells in human gastric cancer. PLoS One. 2011;6(3):e17687.[25] Shitara K, Doi T, Nagano O, et al. Dose-escalation study for the targeting of CD44v+ cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205). Gastric Cancer. 2017;20(2):341-349.[26] Kulkarni M, Tan TZ, Syed Sulaiman NB, et al. RUNX1 and RUNX3 protect against YAP-mediated EMT, stem-ness and shorter survival outcomes in breast cancer. Oncotarget. 2018; 9(18):14175-14192. [27] Brabletz T, Kalluri R, Nieto MA, et al. EMT in cancer. Nat Rev Cancer. 2018;18(2):128-134.[28] Suarez-Carmona M, Lesage J, Cataldo D, et al. EMT and inflammation: inseparable actors of cancer progression. Mol Oncol. 2017;11(7):805-823.[29] Wang J, Wang X, Liu F, et al. microRNA-335 inhibits colorectal cancer HCT116 cells growth and epithelial- mesenchymal transition (EMT) process by targeting Twist1. Pharmazie. 2017;72(8):475-481.[30] Tang CP, Zhou HJ, Qin J, et al. MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer. Oncol Rep. 2017;38(5): 3144-3152.[31] Lu Z, Nian Z, Jingjing Z, et al. MicroRNA-424/E2F6 feedback loop modulates cell invasion, migration and EMT in endometrial carcinoma. Oncotarget. 2017;8(69): 114281-114291. [32] Pereira-da-Silva T, Coutinho Cruz M, Carrusca C, et al. Circulating microRNA profiles in different arterial territories of stable atherosclerotic disease: a systematic review. Am J Cardiovasc Dis. 2018;8(1):1-13.[33] Deng Z, He Y, Yang X, et al. MicroRNA-29: A Crucial Player in Fibrotic Disease. Mol Diagn Ther. 2017;21(3):285-294.[34] Ma C, Huang T, Ding YC, et al. MicroRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells. Int J Clin Exp Pathol. 2015;8(6):6533-6539.[35] Yu D, Shin HS, Lee YS, et al. miR-106b modulates cancer stem cell characteristics through TGF-β/Smad signaling in CD44-positive gastric cancer cells. Lab Invest. 2014;94(12): 1370-1381. [36] Yang JP, Yang JK, Li C, et al. Downregulation of ZMYND11 induced by miR-196a-5p promotes the progression and growth of GBM. Biochem Biophys Res Commun. 2017;494 (3-4):674-680.[37] Maruyama T, Nishihara K, Umikawa M, et al. MicroRNA-196a-5p is a potential prognostic marker of delayed lymph node metastasis in early-stage tongue squamous cell carcinoma. Oncol Lett. 2018;15(2):2349-2363.[38] Zhang W, Li Y. miR-148a downregulates the expression of transforming growth factor-β2 and SMAD2 in gastric cancer. Int J Oncol. 2016;48(5):1877-1885.[39] Wang XH, Liu MN, Sun X, et al. TGF-β1 pathway affects the protein expression of many signaling pathways, markers of liver cancer stem cells, cytokeratins, and TERT in liver cancer HepG2 cells. Tumour Biol. 2016;37(3):3675-3681.[40] Liu TJ, Guo JL, Wang HK, et al. Semaphorin-7A contributes to growth, migration and invasion of oral tongue squamous cell carcinoma through TGF-β-mediated EMT signaling pathway.Eur Rev Med Pharmacol Sci. 2018;22(4):1035-1043.[41] Goto M, Osada S, Imagawa M, et al. FAD104, a regulator of adipogenesis, is a novel suppressor of TGF-β-mediated EMT in cervical cancer cells. Sci Rep. 2017;7(1):16365.[42] Yang H, Zhan L Yang T, et al. Ski prevents TGF-β-induced EMT and cell invasion by repressing SMAD-dependent signaling in non-small cell lung cancer. Oncol Rep. 2015; 34(1):87-94. |